spec sheet6 rows
Ropivacaine is a long acting amide local anaesthetic developed as a safer alternative to bupivacaine, used for surgical epidurals, nerve blocks and labour analgesia.
- Ropivacaine is the pure S(-)-enantiomer of a propyl homologue of bupivacaine; single-enantiomer design was the deliberate strategy for reducing the cardiotoxicity that made racemic bupivacaine notorious.
- Knudsen's volunteer study infused ropivacaine, bupivacaine and placebo intravenously and found subjects tolerated a larger dose of ropivacaine before central nervous system symptoms, with less depression of cardiac conductivity and contractility [1]; the study that underwrites the safety claim.
- Polley's minimum local analgesic concentration study found ropivacaine is about 0.6 times as potent as bupivacaine for epidural labour analgesia [2], so part of the apparent safety advantage disappears when the drugs are compared at equipotent doses.
- Halpern's meta-analysis of labour epidurals found ropivacaine associated with less motor block and fewer instrumental deliveries than bupivacaine, though the effect size is modest and partly potency-dependent [3].
- Head to head, ropivacaine is also less potent than levobupivacaine, the other single-enantiomer alternative to racemic bupivacaine [4].
- Ropivacaine causes intrinsic vasoconstriction at clinical concentrations, so unlike lidocaine it does not need added adrenaline to prolong the block.
Mechanism
It blocks voltage gated sodium channels like the rest of the amide class, but it is supplied as the pure S- and is less lipid soluble than bupivacaine, which is what lowers its affinity for cardiac sodium channels. At low concentration it also separates sensory from motor block, so a labouring patient can still move her legs.
receptor fingerprint
Voltage-gated sodium channels in peripheral nerve axonsUse-dependent (phasic) blocker; pure S(-)-enantiomer
Cardiac sodium channel Nav1.5Blocker with faster dissociation kinetics than R(+)-bupivacaine
Small-diameter A-delta and C sensory fibres relative to large A-alpha motor fibresPreferentially blocked
Vascular smooth muscleIntrinsic vasoconstriction at low concentrations
CYP1A2 (major) and CYP3A4 (minor)Substrate; metabolised to 3-hydroxy-ropivacaine
Safetyrisks and cautions, not medical advice
an injectable anaesthetic for epidural, nerve block and labour analgesia; it is less cardiotoxic than bupivacaine but still causes systemic toxicity with seizures and cardiac depression if it reaches a vessel, and every legitimate use requires a clinician placing the needle
Subjective profileweighing the evidence above
Refused on sourcing for the route rather than the molecule: this goes into an epidural space or against a named nerve, and what a clinic is really providing is the needle placement, not the drug. It is genuinely the safer half of the long acting amide pair, less cardiotoxic than bupivacaine and better at sparing motor function, which is why it took over labour analgesia. None of that helps if it reaches a vessel, where seizures and cardiac depression arrive within a minute and the treatment is a resuscitation trolley already in the room.
Resources
No suppliers are provided for compounds like this. This entry is here for reference.
Research
- 1997first citedCentral nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and pl…
- 2015most recentEpidural Analgesia With Bupivacaine and Fentanyl Versus Ropivacaine and Fentanyl for Pain Relie…
- 1.Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers
- 2.Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: implications for therapeutic indexes
- 3.Epidural ropivacaine versus bupivacaine for labor: a meta-analysis
- 4.Relative analgesic potencies of levobupivacaine and ropivacaine for epidural analgesia in labor
- 5.Epidural Analgesia With Bupivacaine and Fentanyl Versus Ropivacaine and Fentanyl for Pain Relief in Labor: A Meta-Analysis
5 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
Notes and cautions
- Ropivacaine carries no boxed warning, and its central claim is a wider margin between central nervous system and cardiovascular toxicity than racemic bupivacaine, but it is not free of local anaesthetic systemic toxicity: seizures and cardiac arrest have followed inadvertent intravascular injection, and treatment requires airway support, benzodiazepines and intravenous lipid emulsion rescue.
- It must not be used for intravenous regional anaesthesia (Bier block) or for obstetric paracervical block, and the 0.5% and higher concentrations are not intended for obstetric epidural bolus, where the 0.75% concentration of bupivacaine caused the historical cardiac arrests that led to this class of restriction.
- Careful incremental dosing with aspiration and, where appropriate, a test dose remains mandatory.
- Part of the apparent safety advantage reflects lower potency (minimum local analgesic concentration ratio about 0.6 versus bupivacaine), so equipotent comparisons narrow the gap; chondrolysis has been reported after intra-articular infusion, which is not an approved use.